- Chemotherapy (Taxotere) Lawsuits for Permanent Hair Loss
- July 7, 2016
- Law Firm: Buckfire Buckfire P.C. - Southfield Office
Women who have been wrongfully harmed by the chemotherapy drug Taxotere are pursing claims against French drug maker Sanofi-Aventis. Taxotere is known to cause permanent hair loss in women but this fact was not disclosed to consumers or physicians by the pharmaceutical company. Other cancer drugs, without this side-effect, could have been used to combat the disease instead of Taxotere.
Several recently filed lawsuits allege that the drug company failed to warn doctors and women that the medication can cause permanent hair loss. Because similar medications cause only temporary hair loss, these women were not properly informed of their options for a different drug. Permanent hair loss, known as alopecia, can have devastating psychological consequences on women who survive their battle with cancer..
Settlements in these potential cases are expected to be substantial. You may be entitled to receive compensation for your suffering if you suffered permanent hair loss from this cancer drug. Settlements in dangerous drug lawsuits provide compensation for psychological damage and emotional injuries suffered by women. Damages also include medical expenses and lost wages.
If you suffered permanent hair loss from taking Taxotere, you may be eligible for a lawsuit against drug maker Sanofi-Aventis. To qualify for current cases, you must meet the following criteria:
- Be female
- Diagnosed with cancer in 1996 or after
- Had gone chemotherapy treatment
- Was treated with Taxotere or the generic drug Doxetaxel
Our legal team will review your medical records to determine if you have a case. If you do qualify for a claim, we will start your case immediately. There are strict deadlines for filing dangerous drug lawsuits so you should contact our attorneys immediately if you meet the case criteria requirements. Call us at (866) 280-3417 to learn more.